Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Celia Oreja-Guevara

Associate Professor

Universidad Complutense de Madrid

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Articles (10)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Collaborators (8)

Michael Levy

Massachusetts General Hospital

UNITED STATES

View details

Ana Maria Alonso Torres

Instituto de Investigación Biomédica de Málaga

SPAIN

View details

Jose Maria Rumbo-Prieto

Profesor Asociado

Universidade da Coruña

SPAIN

View details

Achim Berthele

school of medicine technische universität münchen munich germany

GERMANY

View details

Filipe Palavra

Director

Hospitais da Universidade de Coimbra

PORTUGAL

View details

Sean Pittock

Chair, Department of Neurology

Mayo Clinic

UNITED STATES

View details

Jan Lycke

Consultant/Professor

Sahlgrenska universitetssjukhuset

SWEDEN

View details

Ichiro Nakashima

Professor

Tohoku Medical and Pharmaceutical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Celia Oreja-Guevara

Research Interests

Make your next move.

Explore related searches

Articles (10)

From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody–Positive Neuromyelitis Optica Spectrum Disorder

Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4‐Year CASTING–LIBERTO Trial

Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group

Mitochondrial function of peripheral lymphocytes: role on multiple sclerosis clinical subtypes

Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab

Twenty years of natalizumab in multiple sclerosis: lessons learned and future outlook

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

Collaborators (8)

Michael Levy

Ana Maria Alonso Torres

Jose Maria Rumbo-Prieto

Achim Berthele

Filipe Palavra

Sean Pittock

Jan Lycke

Ichiro Nakashima

Make your next move.